EMPOWER PHARMACY
Live / Registered — Registered (as of 18 Mar 2025)
What this means for you
Registered since 18 Mar 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Mar 2031: the §8 declaration of use).
Record
- Serial number
- 98512813
- Registration number
- 7729145
- Mark type
- Word mark
- Filed
- 22 Apr 2024
- Published for opposition
- 15 Oct 2024
- Registered
- 18 Mar 2025
- Next maintenance filing
- §8 declaration of use, due by 18 Mar 2031 (grace period to 18 Sept 2031)
- Attorney of record
- John A. Yates
Goods and services
- Class 035 — Advertising and business services: Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical compounding services; preparation of prescriptions by pharmacists; medical and pharmaceutical consultation
Owner
- Empower Clinic Services, LLC, Houston, TX, US
- Empower Clinic Services, LLC, Houston, TX, US
- Empower Clinic Services, LLC, Houston, TX, US
Board proceedings on this mark
- Extension of Time to Oppose No. 98512813 — EmpowerPharm Inc. v. Empower Clinic Services, LLC, filed 12 Nov 2024 (Terminated)
Prosecution history
- 18 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 23 Feb 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 12 Nov 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jun 2024 — NON-FINAL ACTION E-MAILED
- 29 Jun 2024 — NON-FINAL ACTION WRITTEN
- 28 Jun 2024 — ASSIGNED TO EXAMINER